http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577107-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff77eb998def188ea7dc104d32249c1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0664 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate | 2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece9823ab6ac404759599681e74bb422 |
| publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113577107-A |
| titleOfInvention | A kind of preparation method of stem cell and its application |
| abstract | The invention belongs to the field of biomedicine, and relates to a preparation method and application of stem cells. The present invention provides a method for preparing stem cells, the medium used for the stem cells is serum-free medium, the stem cells are dental pulp mesenchymal stem cells, and the stem cells obtained by the method are used to inhibit activated T cells and immune system diseases Treatment. The research of the present invention found that hMSC-DP obtained under serum-free medium culture has a stronger ability to induce T cell apoptosis than cells obtained under serum-cultured culture, and at the same time, serum-free cultured hMSC-DP is used for the treatment of DSS Induced acute colitis, it was found that the serum-free cultured hMSC-DP of the P5 and P10 generations had a strong therapeutic ability, suggesting that the serum-free cultured hMSC-DP has a strong potential for the treatment of immune diseases. |
| priorityDate | 2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 452.